nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Epirubicin—uterine cancer	0.148	0.519	CrCtD
Idarubicin—Doxorubicin—uterine cancer	0.137	0.48	CrCtD
Idarubicin—Anthracyclines—Epirubicin—uterine cancer	0.0989	0.271	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—uterine cancer	0.0915	0.251	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Etoposide—uterine cancer	0.0751	0.206	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—uterine cancer	0.0517	0.142	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—uterine cancer	0.0478	0.131	CiPCiCtD
Idarubicin—Doxorubicin—Epirubicin—uterine cancer	0.0317	0.173	CrCrCtD
Idarubicin—Valrubicin—Epirubicin—uterine cancer	0.0317	0.173	CrCrCtD
Idarubicin—Daunorubicin—Epirubicin—uterine cancer	0.0317	0.173	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—uterine cancer	0.0293	0.16	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—uterine cancer	0.0293	0.16	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—uterine cancer	0.0293	0.16	CrCrCtD
Idarubicin—TOP2A—Epirubicin—uterine cancer	0.0207	0.161	CbGbCtD
Idarubicin—ABCC1—Progesterone—uterine cancer	0.02	0.155	CbGbCtD
Idarubicin—TOP2A—Etoposide—uterine cancer	0.0161	0.125	CbGbCtD
Idarubicin—ABCC1—Dactinomycin—uterine cancer	0.0158	0.123	CbGbCtD
Idarubicin—ABCC1—Epirubicin—uterine cancer	0.0115	0.0893	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—uterine cancer	0.011	0.0856	CbGbCtD
Idarubicin—ABCC1—Etoposide—uterine cancer	0.00894	0.0696	CbGbCtD
Idarubicin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0075	0.0583	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—uterine cancer	0.0061	0.0474	CbGbCtD
Idarubicin—CYP2C9—Progesterone—uterine cancer	0.00497	0.0386	CbGbCtD
Idarubicin—CYP2D6—Progesterone—uterine cancer	0.00454	0.0353	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—uterine cancer	0.00139	0.0108	CbGbCtD
Idarubicin—Doxorubicin—AKR1C3—uterine cancer	0.000468	1	CrCbGaD
Idarubicin—TOP2A—myometrium—uterine cancer	0.00029	0.0959	CbGeAlD
Idarubicin—TOP2A—uterine cervix—uterine cancer	0.000226	0.0746	CbGeAlD
Idarubicin—TOP2A—decidua—uterine cancer	0.000215	0.0711	CbGeAlD
Idarubicin—TOP2A—endometrium—uterine cancer	0.000204	0.0675	CbGeAlD
Idarubicin—TOP2A—mammalian vulva—uterine cancer	0.000197	0.0653	CbGeAlD
Idarubicin—TOP2A—uterus—uterine cancer	0.000188	0.0622	CbGeAlD
Idarubicin—ABCC1—myometrium—uterine cancer	0.000175	0.0577	CbGeAlD
Idarubicin—TOP2A—female gonad—uterine cancer	0.000154	0.0509	CbGeAlD
Idarubicin—TOP2A—vagina—uterine cancer	0.000153	0.0506	CbGeAlD
Idarubicin—ABCC1—uterine cervix—uterine cancer	0.000136	0.0449	CbGeAlD
Idarubicin—ABCC1—decidua—uterine cancer	0.000129	0.0428	CbGeAlD
Idarubicin—ABCC1—endometrium—uterine cancer	0.000123	0.0406	CbGeAlD
Idarubicin—ABCC1—mammalian vulva—uterine cancer	0.000119	0.0393	CbGeAlD
Idarubicin—ABCC1—uterus—uterine cancer	0.000113	0.0374	CbGeAlD
Idarubicin—TOP2A—Teniposide—Etoposide—uterine cancer	0.000109	0.157	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—uterine cancer	0.000109	0.157	CbGdCrCtD
Idarubicin—TOP2A—lymph node—uterine cancer	9.89e-05	0.0327	CbGeAlD
Idarubicin—Hyperuricaemia—Etoposide—uterine cancer	9.44e-05	0.00271	CcSEcCtD
Idarubicin—ABCC1—female gonad—uterine cancer	9.26e-05	0.0306	CbGeAlD
Idarubicin—Ulcer—Etoposide—uterine cancer	9.25e-05	0.00266	CcSEcCtD
Idarubicin—ABCC1—vagina—uterine cancer	9.2e-05	0.0304	CbGeAlD
Idarubicin—Body temperature increased—Carboplatin—uterine cancer	9.19e-05	0.00264	CcSEcCtD
Idarubicin—Bundle branch block—Doxorubicin—uterine cancer	9e-05	0.00258	CcSEcCtD
Idarubicin—Embolism venous—Doxorubicin—uterine cancer	9e-05	0.00258	CcSEcCtD
Idarubicin—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	8.92e-05	0.128	CbGdCrCtD
Idarubicin—Blood uric acid increased—Etoposide—uterine cancer	8.91e-05	0.00256	CcSEcCtD
Idarubicin—Cardiomyopathy—Doxorubicin—uterine cancer	8.87e-05	0.00255	CcSEcCtD
Idarubicin—Local reaction—Epirubicin—uterine cancer	8.86e-05	0.00255	CcSEcCtD
Idarubicin—Mucosal inflammation—Epirubicin—uterine cancer	8.86e-05	0.00255	CcSEcCtD
Idarubicin—Haemoglobin—Progesterone—uterine cancer	8.64e-05	0.00248	CcSEcCtD
Idarubicin—Haemorrhage—Progesterone—uterine cancer	8.59e-05	0.00247	CcSEcCtD
Idarubicin—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	8.55e-05	0.00246	CcSEcCtD
Idarubicin—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	8.5e-05	0.00244	CcSEcCtD
Idarubicin—Urinary tract disorder—Progesterone—uterine cancer	8.49e-05	0.00244	CcSEcCtD
Idarubicin—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	8.45e-05	0.00243	CcSEcCtD
Idarubicin—Urethral disorder—Progesterone—uterine cancer	8.42e-05	0.00242	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Epirubicin—uterine cancer	8.25e-05	0.00237	CcSEcCtD
Idarubicin—Mucosal inflammation—Doxorubicin—uterine cancer	8.2e-05	0.00236	CcSEcCtD
Idarubicin—Local reaction—Doxorubicin—uterine cancer	8.2e-05	0.00236	CcSEcCtD
Idarubicin—Febrile neutropenia—Epirubicin—uterine cancer	8.16e-05	0.00234	CcSEcCtD
Idarubicin—Oesophagitis—Etoposide—uterine cancer	8e-05	0.0023	CcSEcCtD
Idarubicin—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	7.83e-05	0.00225	CcSEcCtD
Idarubicin—Angiopathy—Progesterone—uterine cancer	7.8e-05	0.00224	CcSEcCtD
Idarubicin—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	7.79e-05	0.00224	CcSEcCtD
Idarubicin—TOP2A—Methyltestosterone—Progesterone—uterine cancer	7.77e-05	0.112	CbGdCrCtD
Idarubicin—Immune system disorder—Progesterone—uterine cancer	7.76e-05	0.00223	CcSEcCtD
Idarubicin—CYP2C9—female reproductive system—uterine cancer	7.7e-05	0.0255	CbGeAlD
Idarubicin—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	7.69e-05	0.00221	CcSEcCtD
Idarubicin—Embolism—Epirubicin—uterine cancer	7.64e-05	0.0022	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Doxorubicin—uterine cancer	7.63e-05	0.00219	CcSEcCtD
Idarubicin—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	7.63e-05	0.00219	CcSEcCtD
Idarubicin—Sepsis—Etoposide—uterine cancer	7.6e-05	0.00218	CcSEcCtD
Idarubicin—Alopecia—Progesterone—uterine cancer	7.59e-05	0.00218	CcSEcCtD
Idarubicin—Febrile neutropenia—Doxorubicin—uterine cancer	7.55e-05	0.00217	CcSEcCtD
Idarubicin—Malnutrition—Progesterone—uterine cancer	7.48e-05	0.00215	CcSEcCtD
Idarubicin—Phlebitis—Etoposide—uterine cancer	7.38e-05	0.00212	CcSEcCtD
Idarubicin—Bone marrow depression—Epirubicin—uterine cancer	7.27e-05	0.00209	CcSEcCtD
Idarubicin—CYP2D6—renal system—uterine cancer	7.21e-05	0.0239	CbGeAlD
Idarubicin—Pancytopenia—Dactinomycin—uterine cancer	7.21e-05	0.00207	CcSEcCtD
Idarubicin—Neutropenia—Dactinomycin—uterine cancer	7.1e-05	0.00204	CcSEcCtD
Idarubicin—Embolism—Doxorubicin—uterine cancer	7.07e-05	0.00203	CcSEcCtD
Idarubicin—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	7.06e-05	0.00203	CcSEcCtD
Idarubicin—Burning sensation—Epirubicin—uterine cancer	7.06e-05	0.00203	CcSEcCtD
Idarubicin—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	7.03e-05	0.00202	CcSEcCtD
Idarubicin—Cardiac failure congestive—Etoposide—uterine cancer	7.01e-05	0.00201	CcSEcCtD
Idarubicin—Chills—Medroxyprogesterone Acetate—uterine cancer	6.99e-05	0.00201	CcSEcCtD
Idarubicin—Anaemia—Progesterone—uterine cancer	6.91e-05	0.00199	CcSEcCtD
Idarubicin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	6.88e-05	0.00198	CcSEcCtD
Idarubicin—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	6.78e-05	0.00195	CcSEcCtD
Idarubicin—Bone marrow depression—Doxorubicin—uterine cancer	6.73e-05	0.00193	CcSEcCtD
Idarubicin—Stomatitis—Dactinomycin—uterine cancer	6.59e-05	0.00189	CcSEcCtD
Idarubicin—Burning sensation—Doxorubicin—uterine cancer	6.53e-05	0.00188	CcSEcCtD
Idarubicin—Convulsion—Progesterone—uterine cancer	6.48e-05	0.00186	CcSEcCtD
Idarubicin—Chest pain—Progesterone—uterine cancer	6.37e-05	0.00183	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	6.32e-05	0.00182	CcSEcCtD
Idarubicin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	6.27e-05	0.0018	CcSEcCtD
Idarubicin—Necrosis—Epirubicin—uterine cancer	6.25e-05	0.0018	CcSEcCtD
Idarubicin—Anaphylactic shock—Progesterone—uterine cancer	6.11e-05	0.00175	CcSEcCtD
Idarubicin—Infection—Progesterone—uterine cancer	6.07e-05	0.00174	CcSEcCtD
Idarubicin—Shock—Progesterone—uterine cancer	6.01e-05	0.00173	CcSEcCtD
Idarubicin—ABCC1—lymph node—uterine cancer	5.95e-05	0.0197	CbGeAlD
Idarubicin—Skin disorder—Progesterone—uterine cancer	5.93e-05	0.0017	CcSEcCtD
Idarubicin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	5.87e-05	0.00169	CcSEcCtD
Idarubicin—Anorexia—Progesterone—uterine cancer	5.82e-05	0.00167	CcSEcCtD
Idarubicin—Necrosis—Doxorubicin—uterine cancer	5.78e-05	0.00166	CcSEcCtD
Idarubicin—CYP2D6—female reproductive system—uterine cancer	5.78e-05	0.0191	CbGeAlD
Idarubicin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	5.77e-05	0.00166	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	5.73e-05	0.00165	CcSEcCtD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—uterine cancer	5.7e-05	0.0819	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—uterine cancer	5.7e-05	0.0819	CbGdCrCtD
Idarubicin—Flushing—Dactinomycin—uterine cancer	5.64e-05	0.00162	CcSEcCtD
Idarubicin—Extravasation—Epirubicin—uterine cancer	5.62e-05	0.00162	CcSEcCtD
Idarubicin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	5.53e-05	0.00159	CcSEcCtD
Idarubicin—Infection—Medroxyprogesterone Acetate—uterine cancer	5.5e-05	0.00158	CcSEcCtD
Idarubicin—Chills—Dactinomycin—uterine cancer	5.45e-05	0.00157	CcSEcCtD
Idarubicin—Shock—Medroxyprogesterone Acetate—uterine cancer	5.44e-05	0.00156	CcSEcCtD
Idarubicin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	5.42e-05	0.00156	CcSEcCtD
Idarubicin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	5.37e-05	0.00154	CcSEcCtD
Idarubicin—Alopecia—Dactinomycin—uterine cancer	5.37e-05	0.00154	CcSEcCtD
Idarubicin—Decreased appetite—Progesterone—uterine cancer	5.31e-05	0.00152	CcSEcCtD
Idarubicin—Hyperuricaemia—Epirubicin—uterine cancer	5.29e-05	0.00152	CcSEcCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—uterine cancer	5.27e-05	0.0758	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	5.27e-05	0.0758	CbGdCrCtD
Idarubicin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	5.27e-05	0.00151	CcSEcCtD
Idarubicin—CYP2D6—female gonad—uterine cancer	5.26e-05	0.0174	CbGeAlD
Idarubicin—Pancytopenia—Etoposide—uterine cancer	5.22e-05	0.0015	CcSEcCtD
Idarubicin—Extravasation—Doxorubicin—uterine cancer	5.2e-05	0.00149	CcSEcCtD
Idarubicin—Ulcer—Epirubicin—uterine cancer	5.19e-05	0.00149	CcSEcCtD
Idarubicin—Neutropenia—Etoposide—uterine cancer	5.14e-05	0.00148	CcSEcCtD
Idarubicin—TOP2A—Norethindrone—Progesterone—uterine cancer	5.07e-05	0.0728	CbGdCrCtD
Idarubicin—Atrioventricular block—Epirubicin—uterine cancer	5.06e-05	0.00145	CcSEcCtD
Idarubicin—Blood uric acid increased—Epirubicin—uterine cancer	5e-05	0.00144	CcSEcCtD
Idarubicin—Gastrointestinal pain—Progesterone—uterine cancer	4.99e-05	0.00143	CcSEcCtD
Idarubicin—Hyperuricaemia—Doxorubicin—uterine cancer	4.89e-05	0.00141	CcSEcCtD
Idarubicin—Anaemia—Dactinomycin—uterine cancer	4.89e-05	0.0014	CcSEcCtD
Idarubicin—Urticaria—Progesterone—uterine cancer	4.85e-05	0.00139	CcSEcCtD
Idarubicin—Acute coronary syndrome—Etoposide—uterine cancer	4.83e-05	0.00139	CcSEcCtD
Idarubicin—Body temperature increased—Progesterone—uterine cancer	4.83e-05	0.00139	CcSEcCtD
Idarubicin—Abdominal pain—Progesterone—uterine cancer	4.83e-05	0.00139	CcSEcCtD
Idarubicin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	4.81e-05	0.00138	CcSEcCtD
Idarubicin—Ulcer—Doxorubicin—uterine cancer	4.8e-05	0.00138	CcSEcCtD
Idarubicin—Myocardial infarction—Etoposide—uterine cancer	4.8e-05	0.00138	CcSEcCtD
Idarubicin—Stomatitis—Etoposide—uterine cancer	4.77e-05	0.00137	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—uterine cancer	4.73e-05	0.00136	CcSEcCtD
Idarubicin—Colitis—Epirubicin—uterine cancer	4.71e-05	0.00135	CcSEcCtD
Idarubicin—Atrioventricular block—Doxorubicin—uterine cancer	4.68e-05	0.00134	CcSEcCtD
Idarubicin—Blood uric acid increased—Doxorubicin—uterine cancer	4.62e-05	0.00133	CcSEcCtD
Idarubicin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	4.52e-05	0.0013	CcSEcCtD
Idarubicin—Hypersensitivity—Progesterone—uterine cancer	4.5e-05	0.00129	CcSEcCtD
Idarubicin—Oesophagitis—Epirubicin—uterine cancer	4.48e-05	0.00129	CcSEcCtD
Idarubicin—Neoplasm—Epirubicin—uterine cancer	4.44e-05	0.00127	CcSEcCtD
Idarubicin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	4.39e-05	0.00126	CcSEcCtD
Idarubicin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	4.37e-05	0.00126	CcSEcCtD
Idarubicin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	4.37e-05	0.00126	CcSEcCtD
Idarubicin—Colitis—Doxorubicin—uterine cancer	4.36e-05	0.00125	CcSEcCtD
Idarubicin—Urinary tract disorder—Etoposide—uterine cancer	4.34e-05	0.00125	CcSEcCtD
Idarubicin—Urethral disorder—Etoposide—uterine cancer	4.31e-05	0.00124	CcSEcCtD
Idarubicin—Infection—Dactinomycin—uterine cancer	4.29e-05	0.00123	CcSEcCtD
Idarubicin—Sepsis—Epirubicin—uterine cancer	4.26e-05	0.00122	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—uterine cancer	4.22e-05	0.00121	CcSEcCtD
Idarubicin—Diarrhoea—Progesterone—uterine cancer	4.18e-05	0.0012	CcSEcCtD
Idarubicin—Oesophagitis—Doxorubicin—uterine cancer	4.15e-05	0.00119	CcSEcCtD
Idarubicin—Phlebitis—Epirubicin—uterine cancer	4.13e-05	0.00119	CcSEcCtD
Idarubicin—Thrombophlebitis—Epirubicin—uterine cancer	4.11e-05	0.00118	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—uterine cancer	4.11e-05	0.00118	CcSEcCtD
Idarubicin—Neoplasm—Doxorubicin—uterine cancer	4.1e-05	0.00118	CcSEcCtD
Idarubicin—Flushing—Etoposide—uterine cancer	4.08e-05	0.00117	CcSEcCtD
Idarubicin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	4.08e-05	0.00117	CcSEcCtD
Idarubicin—Hepatic function abnormal—Epirubicin—uterine cancer	4.08e-05	0.00117	CcSEcCtD
Idarubicin—TOP2A—Levonorgestrel—Progesterone—uterine cancer	4.03e-05	0.0579	CbGdCrCtD
Idarubicin—Angiopathy—Etoposide—uterine cancer	3.99e-05	0.00115	CcSEcCtD
Idarubicin—Immune system disorder—Etoposide—uterine cancer	3.97e-05	0.00114	CcSEcCtD
Idarubicin—Chills—Etoposide—uterine cancer	3.94e-05	0.00113	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—uterine cancer	3.94e-05	0.00113	CcSEcCtD
Idarubicin—Cardiac failure congestive—Epirubicin—uterine cancer	3.93e-05	0.00113	CcSEcCtD
Idarubicin—Alopecia—Etoposide—uterine cancer	3.88e-05	0.00112	CcSEcCtD
Idarubicin—Vomiting—Progesterone—uterine cancer	3.88e-05	0.00111	CcSEcCtD
Idarubicin—Rash—Progesterone—uterine cancer	3.85e-05	0.00111	CcSEcCtD
Idarubicin—Dermatitis—Progesterone—uterine cancer	3.85e-05	0.0011	CcSEcCtD
Idarubicin—Phlebitis—Doxorubicin—uterine cancer	3.83e-05	0.0011	CcSEcCtD
Idarubicin—Headache—Progesterone—uterine cancer	3.82e-05	0.0011	CcSEcCtD
Idarubicin—Hot flush—Epirubicin—uterine cancer	3.81e-05	0.00109	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—uterine cancer	3.81e-05	0.00109	CcSEcCtD
Idarubicin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	3.79e-05	0.00109	CcSEcCtD
Idarubicin—Menopausal symptoms—Epirubicin—uterine cancer	3.77e-05	0.00108	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—uterine cancer	3.77e-05	0.00108	CcSEcCtD
Idarubicin—Decreased appetite—Dactinomycin—uterine cancer	3.75e-05	0.00108	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—uterine cancer	3.63e-05	0.00104	CcSEcCtD
Idarubicin—Nausea—Progesterone—uterine cancer	3.63e-05	0.00104	CcSEcCtD
Idarubicin—Anaemia—Etoposide—uterine cancer	3.54e-05	0.00102	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—uterine cancer	3.53e-05	0.00101	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—uterine cancer	3.52e-05	0.00101	CcSEcCtD
Idarubicin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	3.52e-05	0.00101	CcSEcCtD
Idarubicin—Menopausal symptoms—Doxorubicin—uterine cancer	3.49e-05	0.001	CcSEcCtD
Idarubicin—Rash—Medroxyprogesterone Acetate—uterine cancer	3.49e-05	0.001	CcSEcCtD
Idarubicin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	3.48e-05	0.001	CcSEcCtD
Idarubicin—Headache—Medroxyprogesterone Acetate—uterine cancer	3.47e-05	0.000995	CcSEcCtD
Idarubicin—Leukopenia—Etoposide—uterine cancer	3.43e-05	0.000984	CcSEcCtD
Idarubicin—Body temperature increased—Dactinomycin—uterine cancer	3.41e-05	0.00098	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—uterine cancer	3.41e-05	0.00098	CcSEcCtD
Idarubicin—Convulsion—Etoposide—uterine cancer	3.32e-05	0.000952	CcSEcCtD
Idarubicin—Dehydration—Epirubicin—uterine cancer	3.31e-05	0.000951	CcSEcCtD
Idarubicin—Nausea—Medroxyprogesterone Acetate—uterine cancer	3.29e-05	0.000944	CcSEcCtD
Idarubicin—Chest pain—Etoposide—uterine cancer	3.26e-05	0.000936	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	3.24e-05	0.000929	CcSEcCtD
Idarubicin—Hypersensitivity—Dactinomycin—uterine cancer	3.18e-05	0.000913	CcSEcCtD
Idarubicin—Anaphylactic shock—Etoposide—uterine cancer	3.12e-05	0.000897	CcSEcCtD
Idarubicin—Infection—Etoposide—uterine cancer	3.1e-05	0.000891	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—uterine cancer	3.06e-05	0.00088	CcSEcCtD
Idarubicin—Thrombocytopenia—Etoposide—uterine cancer	3.06e-05	0.000878	CcSEcCtD
Idarubicin—Skin disorder—Etoposide—uterine cancer	3.03e-05	0.000871	CcSEcCtD
Idarubicin—Anorexia—Etoposide—uterine cancer	2.98e-05	0.000855	CcSEcCtD
Idarubicin—Diarrhoea—Dactinomycin—uterine cancer	2.95e-05	0.000848	CcSEcCtD
Idarubicin—Pancytopenia—Epirubicin—uterine cancer	2.92e-05	0.00084	CcSEcCtD
Idarubicin—Neutropenia—Epirubicin—uterine cancer	2.88e-05	0.000827	CcSEcCtD
Idarubicin—Vomiting—Dactinomycin—uterine cancer	2.74e-05	0.000788	CcSEcCtD
Idarubicin—Rash—Dactinomycin—uterine cancer	2.72e-05	0.000782	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—uterine cancer	2.71e-05	0.00078	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—uterine cancer	2.71e-05	0.000777	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—uterine cancer	2.68e-05	0.000769	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—uterine cancer	2.66e-05	0.000765	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—uterine cancer	2.56e-05	0.000736	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—uterine cancer	2.55e-05	0.000734	CcSEcCtD
Idarubicin—Urticaria—Etoposide—uterine cancer	2.48e-05	0.000713	CcSEcCtD
Idarubicin—Haemoglobin—Epirubicin—uterine cancer	2.48e-05	0.000711	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—uterine cancer	2.48e-05	0.000711	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—uterine cancer	2.47e-05	0.000709	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—uterine cancer	2.47e-05	0.000709	CcSEcCtD
Idarubicin—Haemorrhage—Epirubicin—uterine cancer	2.46e-05	0.000708	CcSEcCtD
Idarubicin—Urinary tract disorder—Epirubicin—uterine cancer	2.43e-05	0.000699	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—uterine cancer	2.42e-05	0.000694	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—uterine cancer	2.3e-05	0.000661	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—uterine cancer	2.29e-05	0.000658	CcSEcCtD
Idarubicin—Flushing—Epirubicin—uterine cancer	2.29e-05	0.000657	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—uterine cancer	2.28e-05	0.000655	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—uterine cancer	2.25e-05	0.000647	CcSEcCtD
Idarubicin—Angiopathy—Epirubicin—uterine cancer	2.24e-05	0.000642	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—uterine cancer	2.23e-05	0.000642	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—uterine cancer	2.23e-05	0.000639	CcSEcCtD
Idarubicin—Chills—Epirubicin—uterine cancer	2.21e-05	0.000635	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—uterine cancer	2.2e-05	0.000632	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—uterine cancer	2.18e-05	0.000625	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—uterine cancer	2.15e-05	0.000616	CcSEcCtD
Idarubicin—Diarrhoea—Etoposide—uterine cancer	2.14e-05	0.000614	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—uterine cancer	2.12e-05	0.000608	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—uterine cancer	2.07e-05	0.000594	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—uterine cancer	2.06e-05	0.000592	CcSEcCtD
Idarubicin—Chills—Doxorubicin—uterine cancer	2.05e-05	0.000588	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—uterine cancer	2.04e-05	0.000585	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—uterine cancer	2.01e-05	0.000579	CcSEcCtD
Idarubicin—Vomiting—Etoposide—uterine cancer	1.99e-05	0.00057	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—uterine cancer	1.98e-05	0.00057	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—uterine cancer	1.98e-05	0.000569	CcSEcCtD
Idarubicin—Rash—Etoposide—uterine cancer	1.97e-05	0.000566	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—uterine cancer	1.97e-05	0.000565	CcSEcCtD
Idarubicin—Headache—Etoposide—uterine cancer	1.96e-05	0.000562	CcSEcCtD
Idarubicin—Leukopenia—Epirubicin—uterine cancer	1.92e-05	0.000552	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—uterine cancer	1.86e-05	0.000534	CcSEcCtD
Idarubicin—Nausea—Etoposide—uterine cancer	1.86e-05	0.000533	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—uterine cancer	1.83e-05	0.000527	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—uterine cancer	1.83e-05	0.000525	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	1.81e-05	0.000521	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—uterine cancer	1.78e-05	0.00051	CcSEcCtD
Idarubicin—Anaphylactic shock—Epirubicin—uterine cancer	1.75e-05	0.000503	CcSEcCtD
Idarubicin—Infection—Epirubicin—uterine cancer	1.74e-05	0.0005	CcSEcCtD
Idarubicin—Shock—Epirubicin—uterine cancer	1.72e-05	0.000495	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—uterine cancer	1.72e-05	0.000494	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—uterine cancer	1.71e-05	0.000492	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—uterine cancer	1.7e-05	0.000488	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—uterine cancer	1.69e-05	0.000485	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	1.68e-05	0.000482	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—uterine cancer	1.67e-05	0.000479	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—uterine cancer	1.62e-05	0.000465	CcSEcCtD
Idarubicin—Infection—Doxorubicin—uterine cancer	1.61e-05	0.000462	CcSEcCtD
Idarubicin—Shock—Doxorubicin—uterine cancer	1.59e-05	0.000458	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—uterine cancer	1.59e-05	0.000456	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—uterine cancer	1.57e-05	0.000452	CcSEcCtD
Idarubicin—Anorexia—Doxorubicin—uterine cancer	1.54e-05	0.000444	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—uterine cancer	1.52e-05	0.000437	CcSEcCtD
Idarubicin—Gastrointestinal pain—Epirubicin—uterine cancer	1.43e-05	0.000411	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—uterine cancer	1.41e-05	0.000404	CcSEcCtD
Idarubicin—Urticaria—Epirubicin—uterine cancer	1.39e-05	0.000399	CcSEcCtD
Idarubicin—Abdominal pain—Epirubicin—uterine cancer	1.38e-05	0.000398	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—uterine cancer	1.38e-05	0.000398	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—uterine cancer	1.32e-05	0.00038	CcSEcCtD
Idarubicin—Hypersensitivity—Epirubicin—uterine cancer	1.29e-05	0.00037	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—uterine cancer	1.29e-05	0.00037	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—uterine cancer	1.28e-05	0.000368	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—uterine cancer	1.28e-05	0.000368	CcSEcCtD
Idarubicin—Diarrhoea—Epirubicin—uterine cancer	1.2e-05	0.000344	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—uterine cancer	1.19e-05	0.000343	CcSEcCtD
Idarubicin—Vomiting—Epirubicin—uterine cancer	1.11e-05	0.00032	CcSEcCtD
Idarubicin—Diarrhoea—Doxorubicin—uterine cancer	1.11e-05	0.000318	CcSEcCtD
Idarubicin—Rash—Epirubicin—uterine cancer	1.1e-05	0.000317	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—uterine cancer	1.1e-05	0.000317	CcSEcCtD
Idarubicin—Headache—Epirubicin—uterine cancer	1.1e-05	0.000315	CcSEcCtD
Idarubicin—Nausea—Epirubicin—uterine cancer	1.04e-05	0.000299	CcSEcCtD
Idarubicin—Vomiting—Doxorubicin—uterine cancer	1.03e-05	0.000296	CcSEcCtD
Idarubicin—Rash—Doxorubicin—uterine cancer	1.02e-05	0.000293	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—uterine cancer	1.02e-05	0.000293	CcSEcCtD
Idarubicin—Headache—Doxorubicin—uterine cancer	1.01e-05	0.000291	CcSEcCtD
Idarubicin—Nausea—Doxorubicin—uterine cancer	9.62e-06	0.000276	CcSEcCtD
